Liver disease in childhood: principles of management.
作者信息
Williams R
出版信息
Postgrad Med J. 1974 Jun;50(584):381-5. doi: 10.1136/pgmj.50.584.381.
Abstract
摘要
相似文献
1
Liver disease in childhood: principles of management.儿童肝病：管理原则
Postgrad Med J. 1974 Jun;50(584):381-5. doi: 10.1136/pgmj.50.584.381.
2
Treatment of chronic active hepatitis in children.儿童慢性活动性肝炎的治疗
Postgrad Med J. 1974 Jun;50(584):386-91. doi: 10.1136/pgmj.50.584.386.
3
[Indications for and results of immunosupressive therapy in childhood chronic active hepatitis].
Monatsschr Kinderheilkd (1902). 1975 Aug;123(8):630-20.
4
Therapeutic considerations in selected forms of acute and chronic liver disease.特定类型急慢性肝病的治疗考量
Med Clin North Am. 1971 Mar;55(2):373-90. doi: 10.1016/s0025-7125(16)32526-3.
5
Anticomplementary hepatitis B antigen. Prognostic importance in chronic active liver disease.抗补体乙肝抗原。在慢性活动性肝病中的预后重要性。
Arch Intern Med. 1973 Oct;132(4):502-5. doi: 10.1001/archinte.132.4.502.
6
7
8
[Chronic viral hepatitis in childhood. 24 cases including 5 sibling pairs].[儿童慢性病毒性肝炎。24例，包括5对同胞]
Infection. 1973;1(4):200-4. doi: 10.1007/BF01639649.
9
[Indications and management of immunosuppressive therapy in chronic hepatitis].[慢性肝炎免疫抑制治疗的适应证与管理]
Schweiz Med Wochenschr. 1973 Feb 3;103(5):158-61.
10
Chronic active hepatitis in children.
Am J Dig Dis. 1972 Jul;17(7):575-82. doi: 10.1007/BF02231742.
引用本文的文献
1
Pediatric gastroenterology 1/1/69-12/31/75: a review. Part II. The liver and biliary tract.小儿胃肠病学1969年1月1日至1975年12月31日：综述。第二部分。肝脏和胆道。
Am J Dig Dis. 1977 Feb;22(2):155-67. doi: 10.1007/BF01072961.
本文引用的文献
1
The treatment of active chronic hepatitis with 6-mercaptopurine and azathioprine.用6-巯基嘌呤和硫唑嘌呤治疗活动性慢性肝炎。
Australas Ann Med. 1967 Nov;16(4):305-11. doi: 10.1111/imj.1967.16.4.305.
2
Significance of azathioprine metabolites.硫唑嘌呤代谢物的意义。
Proc R Soc Med. 1972 Mar;65(3):257-60. doi: 10.1177/003591577206500315.
3
Disorderd hemostasis in liver damage from paracetamol overdose.对乙酰氨基酚过量所致肝损伤中的止血功能紊乱
Gastroenterology. 1973 Nov;65(5):788-95.
4
Plasma and brain tryptophan changes in experimental acute hepatic failure.实验性急性肝衰竭时血浆及脑内色氨酸的变化
J Neurochem. 1973 Jul;21(1):137-45. doi: 10.1111/j.1471-4159.1973.tb04233.x.
5
Immunosuppressive activity in patients with active chronic hepatitis and primary biliary cirrhosis treated with azathioprine.接受硫唑嘌呤治疗的活动性慢性肝炎和原发性胆汁性肝硬化患者的免疫抑制活性。
Gut. 1972 Nov;13(11):907-14. doi: 10.1136/gut.13.11.907.
6
Corticosteroids in liver disease: studies on the biological conversion of prednisone to prednisolone and plasma protein binding.肝脏疾病中的皮质类固醇：关于泼尼松向泼尼松龙的生物转化及血浆蛋白结合的研究
Gut. 1972 Sep;13(9):690-6. doi: 10.1136/gut.13.9.690.
7
Hepatic encephalopathy.肝性脑病
J R Coll Physicians Lond. 1973 Oct;8(1):63-74.
8
Serum immunosuppressive activity of azathioprine in normal subjects and patients with liver diseases.硫唑嘌呤在正常受试者和肝病患者中的血清免疫抑制活性。
Proc R Soc Med. 1972 Mar;65(3):260-3. doi: 10.1177/003591577206500316.
9
Problems of fulminant hepatic failure.暴发性肝衰竭的问题。
Br Med Bull. 1972 May;28(2):114-9. doi: 10.1093/oxfordjournals.bmb.a070908.
Zotero 插件